Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Assets (2021 - 2026)

Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Non-Current Assets came in at $9.3 million in Q1 2026, up 2564.36% year-on-year from $350793.0 in Q1 2025, and down 6.28% quarter-over-quarter from $10.0 million in Q4 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Assets (2021 - 2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Non-Current Assets history runs 6 years deep, the most recent figure standing at $9.3 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 2564.36% year-over-year to $9.3 million in Q1 2026; TTM through Mar 2026 was $19.9 million, a 1448.07% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 3276.43% from the prior year.
  • Non-Current Assets slipped to $9.3 million in Q1 2026 per SHPH's latest filing, from $10.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $10.0 million in Q4 2025 and bottomed at $64616.0 in Q1 2023.
  • The 5-year median for Non-Current Assets is $327665.0 (2024), against an average of $1.5 million.
  • Across the five-year window, Non-Current Assets slumped 47.06% in 2022 and surged 3276.43% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $75194.0 in 2022, then soared by 377.07% to $358731.0 in 2023, then decreased by 17.66% to $295373.0 in 2024, then jumped by 3276.43% to $10.0 million in 2025, then decreased by 6.28% to $9.3 million in 2026.
  • Per Business Quant, the three latest SHPH Non-Current Assets figures stand at $9.3 million (Q1 2026), $10.0 million (Q4 2025), and $277014.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Shuttle Pharmaceuticals Holdings 120,186.04 120,186.04 - 9.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.35 Mn
Dec 31, 2025 9.97 Mn
Sep 30, 2025 277,014.00
Jun 30, 2025 312,512.00
Mar 31, 2025 350,793.00
Dec 31, 2024 295,373.00
Sep 30, 2024 312,217.00
Jun 30, 2024 327,665.00
Mar 31, 2024 342,902.00
Dec 31, 2023 358,731.00
Sep 30, 2023 380,210.00
Jun 30, 2023 393,759.00
Mar 31, 2023 64,616.00
Dec 31, 2022 75,194.00
Sep 30, 2022 92,530.00
Dec 31, 2021 142,026.00